The Differences in the Prevalence of Cardiovascular Disease, Its Risk Factors, and Achievement of Therapeutic Goals among Urban and Rural Primary Care Patients in Poland: Results from the LIPIDOGRAM 2015 Study.

Poland cardiovascular diseases primary health care risk factors rural urban

Journal

Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588

Informations de publication

Date de publication:
30 Nov 2021
Historique:
received: 10 10 2021
revised: 16 11 2021
accepted: 28 11 2021
entrez: 10 12 2021
pubmed: 11 12 2021
medline: 11 12 2021
Statut: epublish

Résumé

A nationwide cross-sectional study, LIPIDOGRAM2015, was carried out in Poland in the years 2015 and 2016. A total of 438 primary care physicians enrolled 13,724 adult patients that sought medical care in primary health care practices. The prevalence of hypertension, diabetes mellitus, dyslipidaemia, and CVD were similar in urban and rural areas (49.5 vs. 49.4%; 13.7 vs. 13.1%; 84.2 vs. 85.2%; 14.4 vs. 14.2%, respectively). The prevalence of obesity (32.3 vs. 37.5%,

Identifiants

pubmed: 34884357
pii: jcm10235656
doi: 10.3390/jcm10235656
pmc: PMC8658414
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : Valeant Pharmaceuticals
ID : unrestricted educational grant

Références

Eur J Prev Cardiol. 2021 Sep 20;28(11):1279-1289
pubmed: 33580789
JAMA. 2017 Jan 17;317(3):280-289
pubmed: 28114552
Lancet. 2016 Apr 2;387(10026):1377-1396
pubmed: 27115820
Croat Med J. 2011 Aug 15;52(4):566-75
pubmed: 21853552
Kardiol Pol. 2015;73(8):676-700
pubmed: 26304155
Ann Epidemiol. 1998 Jan;8(1):3-13
pubmed: 9465988
Eur Heart J. 2011 Jul;32(14):1769-818
pubmed: 21712404
Am J Public Health. 2004 Oct;94(10):1675-8
pubmed: 15451729
N Engl J Med. 2014 Aug 28;371(9):818-27
pubmed: 25162888
Eur Heart J. 2012 Jul;33(13):1635-701
pubmed: 22555213
Pharmacol Res. 2019 Jan;139:460-466
pubmed: 30527895
Lancet. 2018 Nov 10;392(10159):1736-1788
pubmed: 30496103
BMC Public Health. 2017 Aug 11;17(1):651
pubmed: 28800751
Eur Heart J. 2016 Aug 1;37(29):2315-2381
pubmed: 27222591
Arterioscler Thromb Vasc Biol. 1996 Feb;16(2):339-49
pubmed: 8620351
Scand J Public Health. 2020 Nov;48(7):752-761
pubmed: 31464561
J Hypertens. 2018 Dec;36(12):2284-2309
pubmed: 30379783
Int J Environ Res Public Health. 2018 Oct 28;15(11):
pubmed: 30373289
Przegl Epidemiol. 2015;69(1):79-86, 175-80
pubmed: 25862452
BMC Public Health. 2014 Aug 09;14:825
pubmed: 25106746
Diabet Med. 2006 May;23(5):469-80
pubmed: 16681555
Eur Heart J. 2020 Jan 1;41(1):111-188
pubmed: 31504418
Atheroscler Suppl. 2020 Dec;42:e15-e24
pubmed: 33589219

Auteurs

Krzysztof Studziński (K)

Department of Family Medicine, Jagiellonian University Medical College, Bochenska 4, 31-061 Krakow, Poland.

Tomasz Tomasik (T)

Department of Family Medicine, Jagiellonian University Medical College, Bochenska 4, 31-061 Krakow, Poland.

Adam Windak (A)

Department of Family Medicine, Jagiellonian University Medical College, Bochenska 4, 31-061 Krakow, Poland.

Maciej Banach (M)

Polish Mothers Memorial Hospital Research Institute, 93-338 Lodz, Poland.
Department of Hypertension, Chair of Nephrology and Hypertension, Medical University of Lodz, 90-136 Lodz, Poland.
Cardiovascular Research Centre, University of Zielona Gora, 65-417 Zielona Gora, Poland.

Ewa Wójtowicz (E)

Department of Family Medicine, Jagiellonian University Medical College, Bochenska 4, 31-061 Krakow, Poland.

Mirosław Mastej (M)

Mastej Medical Center, 38-200 Jasło, Poland.

Maciej Tomaszewski (M)

Division of Cardiovascular Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester M13 9PT, UK.

Dimitri P Mikhailidis (DP)

Department of Clinical Biochemistry, Royal Free Hospital, University College London, London NW3 2QG, UK.

Peter P Toth (PP)

Cicarrone Center for the Prevention of Cardiovascular Disease, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.
CGH Medical Center, Sterling, IL 61081, USA.

Alberico Catapano (A)

Department of Pharmacological Sciences, University of Milano and Multimedica IRCCS, 20099 Milano, Italy.

Kausik K Ray (KK)

Department of Primary Care and Public Health, Imperial Centre for Cardiovascular Disease Prevention, Imperial College, Kensington, London W6 8RP, UK.

George Howard (G)

Department of Biostatistics, School of Public Health of Alabama at Birmingham, Birmingham B15 2TT, UK.

Gregory Y H Lip (GYH)

Liverpool Centre for Cardiovascular Science, University of Liverpool and Liverpool Heart & Chest Hospital, Liverpool L14 3PE, UK.
Aalborg Thrombosis Research Unit, Department of Clinical Medicine, Aalborg University, 9000 Aalborg, Denmark.

Fadi J Charchar (FJ)

School of Health and Life Sciences, Federation University Australia, Ballarat, VIC 3350, Australia.

Naveed Sattar (N)

Institute of Cardiovascular and Medical Science, University of Glasgow, Glasgow G12 8TA, UK.

Bryan Williams (B)

NIHR University College London Biomedical Research Centre, University College London and University, London NW1 2BU, UK.
College London Hospitals NHS Foundation Trust, London NW1 2BU, UK.

Thomas M MacDonald (TM)

MEMO Research, Ninewells Hospital and Medical School, University of Dundee, Dundee DD1 9SY, UK.

Peter E Penson (PE)

School of Pharmacy and Biomolecular Sciences, Liverpool John Moores University, Liverpool L2 2QP, UK.
Liverpool Centre for Cardiovascular Science, Liverpool L69 7TX, UK.

Jacek J Jóźwiak (JJ)

Department of Family Medicine and Public Health, Institute of Medical Sciences, University of Opole, Oleska 48, 45-052 Opole, Poland.

Classifications MeSH